Oxycodonhydrochlorid Stada (Oxycodone Hydrochloride)

Oxycodone Hydrochloride is used in the management of pain across several clinical contexts.

• Acute postoperative pain: provides rapid relief of moderate to severe pain following surgery.
• Cancer‑related pain: helps control persistent pain associated with malignant disease.
• Chronic non‑cancer pain: used when long‑term opioid therapy is deemed appropriate for conditions such as severe osteoarthritis.
• Trauma‑related pain: alleviates severe pain resulting from injuries such as fractures.
• Palliative care: contributes to comfort in end‑of‑life care by managing severe pain.

• Oxycodone Hydrochloride acts as a full agonist at the μ‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces neuronal excitability, and decreases the release of nociceptive neurotransmitters, resulting in diminished perception of pain.

Adverse reactions to oxy‑hydroxycodone may vary in frequency and severity.

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Nausea: mild to moderate queasiness.
• Drowsiness: increased sedation.
• Dizziness: light‑headed sensation.
• Dry mouth: decreased salivation.
• Pruritus: mild skin itching.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing.
• Severe hypotension: marked drop in blood pressure.
• Opioid use disorder: risk of dependence and addiction.
• Adrenal insufficiency: impaired cortisol production.
• Anaphylaxis: acute allergic reaction.
• Seizures: rare convulsive episodes.

When prescribing oxycodone hydrochloride, clinicians should consider several safety measures.

• Assess pain severity and opioid history: ensure appropriate indication before initiating therapy.
• Monitor for respiratory depression: especially during dose initiation and after dose adjustments.
• Evaluate renal and hepatic function: adjust dosing in impairment.
• Avoid concurrent CNS depressants: limit additive sedation risk.
• Educate patients on constipation management: recommend diet, fluids, and laxatives.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone hydrochloride can interact with a range of concomitant medications.

Major Interactions (Avoid)

• Benzodiazepines: combined use markedly increases risk of respiratory depression.
• Central nervous system depressants: additive sedation and respiratory effects.
• MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole): increase oxycodone plasma levels.
• CYP3A4 inducers (e.g., rifampicin): reduce oxyhydroxy  
• Anticholinergic agents: may worsen constipation.
• Serotonergic drugs: potential for serotonin syndrome.
• Alcohol: enhances sedative effects.